brand names of glp-1 drugs types glp 1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? GLP-1 Medications for Weight Loss:

At the American Diabetes Association (ADA) 2025 conference: Eli Lilly presented bimagrumab plus semaglutide for improved muscle retention

However, GLP-1 peptide agonists currently administered by injection except for oral semaglutide, has stimulated the search for more convenient and orally administered drugs

This may be due to altered -cell function in diabetic patients, which impairs the efficacy of GLP-1(936)

and reduce likelihood of long-term weight maintenance (especially if GLP-1 therapy is stopped)

Reagan-Shaw, S., Nihal, M

In seven large cardiovascular studies, all agents shown at least non-inferiority, with liraglutide, subcutaneous semaglutide, and dulaglutide revealing statistically significant decreases in cardiovascular outcomes (Sheahan et al